Showing 1 - 20 results of 216 for search '(( significant decrease decrease ) OR ( significantly ((lower decrease) OR (marked decrease)) ))~', query time: 0.50s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  6. 6

    <sup>1</sup>H NMR spectra for kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  7. 7

    <sup>13</sup>C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  8. 8

    The structures of T3 and Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  9. 9

    Synthesis process of Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  10. 10

    ESI-HRMS spectra for Kylo-0603. by Xueqin lu (22250795)

    Published 2025
    “…The non-alcoholic steatohepatitis (NASH) activity score (NAS) demonstrated a significant reduction of up to 3.7 points (P < 0.0001), while the fibrosis score decreased by 0.6 points (P < 0.05). …”
  11. 11

    Overview of the parameters used in the model. by Albertus Constantijn Sloof (20405090)

    Published 2024
    “…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”
  12. 12

    Mortality rates per lifecycle stage [28]. by Albertus Constantijn Sloof (20405090)

    Published 2024
    “…Scenario and sensitivity analyses confirm that even with lower vaccination coverage rates, significant benefits are observed: at 10% coverage, the number of infections drops to 115,231, and at 20% coverage, it further reduces to 76,031. …”
  13. 13
  14. 14

    Flow chart of data screening and analysis. by Yan She (8639796)

    Published 2025
    “…In contrast, the BMD, BV/TV, and Tb.N in the 12-week model group exhibited a modest but non-significant decrease relative to the 9-week model group. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20